A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Incyte Corporation
Incyte Corporation
Pfizer
City of Hope Medical Center
Seagen Inc.
Mayo Clinic
OncoNano Medicine, Inc.
UNC Lineberger Comprehensive Cancer Center
Arcus Biosciences, Inc.
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
City of Hope Medical Center
Shattuck Labs, Inc.
Seagen Inc.
Columbia University
City of Hope Medical Center
City of Hope Medical Center
Celldex Therapeutics
Stanford University
Stanford University
University of Nebraska
University of Nebraska
University of Nebraska
NovalGen Ltd.
Eastern Cooperative Oncology Group
Seagen Inc.
Atara Biotherapeutics
Columbia University
Roswell Park Cancer Institute
Opna Bio LLC
Fundación Academia Española de Dermatología
Rutgers, The State University of New Jersey
Northwestern University
Northwestern University
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
miRagen Therapeutics, Inc.
Washington University School of Medicine
National Cancer Institute (NCI)
Incyte Corporation
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center